Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Hogan

Showing results (81-90 of 216) with videos related to

Pageof 22
Sort By:
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|May 18, 2023
Pharmacists' knowledge, perceptions and practices regarding frailty: A cross-sectional survey across practice settings in CanadaPaul Malik, Nardine Nakhla, Yanling Guo, et al.
The Journal of Continuing Education in the Health Professions|August 5, 2005
Assessing outcomes through congruence of course objectives and reflective workJocelyn M Lockyer, Herta Fidler, David B Hogan, et al.
Neuroepidemiology|November 29, 2007
Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E statusKenneth Rockwood, Susan Howlett, John Fisk, et al.
International Journal of Geriatric Psychiatry|October 30, 2024
Association Between Organizational Context and Resident Pain in Assisted Living: A Repeated Cross-Sectional StudyMatthias Hoben, Shovana Shrestha, Hana Dampf, et al.
Plos One|June 24, 2024
Exploring the influence of weather variability and climate change on health outcomes in people living with dementia: A scoping review protocolCamila Astolphi Lima, Sara Alsunaidi, Samuel Lowe, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's diseaseJoseph E Amuah, David B Hogan, Misha Eliasziw, et al.
International Journal of Geriatric Psychiatry|May 8, 2025
Facility-Level Variation of Resident Loneliness in Assisted Living and Associated Organizational Context Factors: A Repeated Cross-Sectional StudyMatthias Hoben, Hana Dampf, Rashmi Devkota, et al.
Archives of Neurology|February 15, 2002
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly peopleKenneth Rockwood, Susan Kirkland, David B Hogan, et al.
BMC Complementary and Alternative Medicine|February 12, 2017
Medication use by middle-aged and older participants of an exercise study: results from the Brain in Motion studyTania Pannu, Sarah Sharkey, Grazyna Burek, et al.
Canadian Geriatrics Journal : CGJ|September 19, 2022
Listening to Trainee Concerns and Suggestions During COVID-19: a Report from the Canadian Consortium on Neurodegeneration in Aging (CCNA)Abdelhady Osman, Amanda Duncan, Patricia Giurca, et al.
Pageof 22

Showing results (81-90 of 216) with videos related to

Sort By:
Pageof 22
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|May 18, 2023
Pharmacists' knowledge, perceptions and practices regarding frailty: A cross-sectional survey across practice settings in CanadaPaul Malik, Nardine Nakhla, Yanling Guo, et al.
The Journal of Continuing Education in the Health Professions|August 5, 2005
Assessing outcomes through congruence of course objectives and reflective workJocelyn M Lockyer, Herta Fidler, David B Hogan, et al.
Neuroepidemiology|November 29, 2007
Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E statusKenneth Rockwood, Susan Howlett, John Fisk, et al.
International Journal of Geriatric Psychiatry|October 30, 2024
Association Between Organizational Context and Resident Pain in Assisted Living: A Repeated Cross-Sectional StudyMatthias Hoben, Shovana Shrestha, Hana Dampf, et al.
Plos One|June 24, 2024
Exploring the influence of weather variability and climate change on health outcomes in people living with dementia: A scoping review protocolCamila Astolphi Lima, Sara Alsunaidi, Samuel Lowe, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's diseaseJoseph E Amuah, David B Hogan, Misha Eliasziw, et al.
International Journal of Geriatric Psychiatry|May 8, 2025
Facility-Level Variation of Resident Loneliness in Assisted Living and Associated Organizational Context Factors: A Repeated Cross-Sectional StudyMatthias Hoben, Hana Dampf, Rashmi Devkota, et al.
Archives of Neurology|February 15, 2002
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly peopleKenneth Rockwood, Susan Kirkland, David B Hogan, et al.
BMC Complementary and Alternative Medicine|February 12, 2017
Medication use by middle-aged and older participants of an exercise study: results from the Brain in Motion studyTania Pannu, Sarah Sharkey, Grazyna Burek, et al.
Canadian Geriatrics Journal : CGJ|September 19, 2022
Listening to Trainee Concerns and Suggestions During COVID-19: a Report from the Canadian Consortium on Neurodegeneration in Aging (CCNA)Abdelhady Osman, Amanda Duncan, Patricia Giurca, et al.
Pageof 22